KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Omega Healthcare Investors (OHI) Interest & Investment Income (2016 - 2025)

Omega Healthcare Investors' Interest & Investment Income history spans 14 years, with the latest figure at $32.4 million for Q4 2025.

  • For Q4 2025, Interest & Investment Income rose 4308.06% year-over-year to $32.4 million; the TTM value through Dec 2025 reached $50.1 million, up 633.34%, while the annual FY2025 figure was $50.1 million, 633.34% up from the prior year.
  • Interest & Investment Income for Q4 2025 was $32.4 million at Omega Healthcare Investors, up from $900000.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $32.4 million in Q4 2025 and bottomed at -$4.4 million in Q2 2022.
  • The 5-year median for Interest & Investment Income is $964500.0 (2023), against an average of $3.7 million.
  • The largest annual shift saw Interest & Investment Income crashed 1117.46% in 2021 before it soared 4308.06% in 2025.
  • A 5-year view of Interest & Investment Income shows it stood at -$585000.0 in 2021, then soared by 619.83% to $3.0 million in 2022, then skyrocketed by 266.52% to $11.1 million in 2023, then plummeted by 106.9% to -$769000.0 in 2024, then skyrocketed by 4308.06% to $32.4 million in 2025.
  • Per Business Quant, the three most recent readings for OHI's Interest & Investment Income are $32.4 million (Q4 2025), $900000.0 (Q3 2025), and $13.8 million (Q2 2025).